United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - calcium folinate - oral tablet - 15mg

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 54 mg (equivalent: folinic acid, qty 50 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections - neutralising the immediate toxic effects of folic acid antagonists, eg methotrexate. treatment of megaloblastic anaemias due to folic acid deficiency, eg in sprue, malnutrition, pregnancy, infancy, liver disease and malabsorption syndromes. folinic acid rescue, ie using calcium folinate in conjunction with folic acid antagonists, eg methotrexate, to minimise systemic toxicity. indications as at 13 jan 05 : leucovorin calcium has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. leucovorin calcium has also shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: calcium folinate, qty 10 mg/ml; equivalent: folinic acid, qty 10 mg/ml) - injection - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide - calcium leucovorin is indicated in:a) neutralising the immediate toxic effects of folic acid antagonists, e.g. methotrexate b) calcium leucovorin rescue - a treatment technique using calcium leucovorin in conjunction with folic acid antagonists, e.g. methotrexate, to minimise systemic toxicity. c) the treatment of megaloblastic anaemias due to sprue, nutritional deficiency, pregnancy, infancy, liver disease and malabsorption syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - calcium folinate 378mg - powder for injection - 350 mg - active: calcium folinate 378mg excipient: hydrochloric acid sodium chloride sodium hydroxide

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - calcium folinate is indicated a) to reduce the toxicity and neutralise the action of folic acid antagonists such as methotrexate in cytotoxic therapy and overdose in adults and children. in cytotoxic therapy, this procedure is commonly known as ?calcium folinate rescue?; b) in combination with 5-fluorouracil in cytotoxic therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate hydrate, quantity: 18.6 mg (equivalent: calcium folinate hydrate, qty 15 mg; equivalent: folinic acid, qty 15 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate - leucovorin calcium has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions.,leucovorin calcium has also shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 16.2 mg (equivalent: folinic acid, qty 15 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections - leucovorin calcium has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. leucovorin calcium has also shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired

Malta - English - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - calcium folinate - tablet - calcium folinate 15 mg - all other therapeutic products